fentanyl has been researched along with Inflammatory Bowel Diseases in 4 studies
Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.
Inflammatory Bowel Diseases: Chronic, non-specific inflammation of the GASTROINTESTINAL TRACT. Etiology may be genetic or environmental. This term includes CROHN DISEASE and ULCERATIVE COLITIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Antinociceptive actions of NFEPP and fentanyl were compared in control mice and mice with dextran sodium sulfate colitis by measuring visceromotor responses to colorectal distension." | 4.12 | Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects. ( Bok, DD; Bunnett, NW; Degro, C; Guzman-Rodriguez, M; Jaramillo-Polanco, JO; Jensen, DD; Jiménez-Vargas, NN; Latorre, R; Lomax, AE; Lopez, C; Margolis, KG; Reed, DE; Schmidt, BL; Snow, Z; Stein, C; Tsang, Q; Vanner, SJ; Wisdom, M; Yu, Y, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Tsuboi, S | 1 |
| Kubota, K | 1 |
| Mihara, T | 1 |
| Taguri, M | 1 |
| Inagawa, G | 1 |
| Goto, T | 1 |
| Steenholdt, C | 1 |
| Jensen, JT | 1 |
| Brynskov, J | 1 |
| Møller, AM | 1 |
| Limschou, AC | 1 |
| Konge, L | 1 |
| Vilmann, P | 1 |
| Jiménez-Vargas, NN | 1 |
| Yu, Y | 1 |
| Jensen, DD | 1 |
| Bok, DD | 1 |
| Wisdom, M | 1 |
| Latorre, R | 1 |
| Lopez, C | 1 |
| Jaramillo-Polanco, JO | 1 |
| Degro, C | 1 |
| Guzman-Rodriguez, M | 1 |
| Tsang, Q | 1 |
| Snow, Z | 1 |
| Schmidt, BL | 1 |
| Reed, DE | 1 |
| Lomax, AE | 1 |
| Margolis, KG | 1 |
| Stein, C | 1 |
| Bunnett, NW | 1 |
| Vanner, SJ | 1 |
| Ahmed, S | 1 |
| Naumann, DN | 1 |
| Karandikar, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Nurse Administered Propofol Sedation vs. Standard Therapy for Colonoscopy in Patients With IBD. A Randomised Controlled Study on Satisfaction and Adherence to Treatment Program.[NCT01934088] | Phase 4 | 130 participants (Actual) | Interventional | 2014-01-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for fentanyl and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Patient Satisfaction of Propofol Versus Midazolam and Fentanyl Sedation During Colonoscopy in Inflammatory Bowel Disease.
Topics: Colonoscopy; Fentanyl; Humans; Hypnotics and Sedatives; Inflammatory Bowel Diseases; Midazolam; Pati | 2022 |
3 other studies available for fentanyl and Inflammatory Bowel Diseases
| Article | Year |
|---|---|
Predictive factors of postoperative fentanyl consumption in patients with inflammatory bowel disease: a retrospective cohort study.
Topics: Analgesia, Patient-Controlled; Analgesics; Analgesics, Opioid; Biological Products; Cohort Studies; | 2022 |
Agonist that activates the µ-opioid receptor in acidified microenvironments inhibits colitis pain without side effects.
Topics: Animals; Colitis; Colon; Colorectal Neoplasms; Constipation; Fentanyl; Humans; Inflammatory Bowel Di | 2022 |
Differences in screening vs non-screening colonoscopy: scope for improvement?
Topics: Adenoma; Adjuvants, Anesthesia; Aged; Anesthetics, Combined; Butylscopolammonium Bromide; Carcinoma; | 2016 |